drug · antibody
patient view →bevacizumab
Phase 3updated 2mo agoby F. Hoffmann-La Roche Ltd🔗 ChEMBL
Phase 3community read0 votes
Antibody drug with a maximum clinical stage of Approval (across all indications), with 20 approved and 146 investigational indications.
indications
indications
NSCLCMelanomaDiabetic Macular Edema
targets
Vascular endothelial growth factor A, long form
all catalysts(5)
phase 1 2 completion · 1
phase 1 2 initiation · 1
phase 1 completion · 1
phase 2 3 completion · 1
phase 2 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that